scPharmaceuticals Inc. is a pharmaceutical company. Co. is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. Co. develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infuser. FUROSCIX is a formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self- administered subcutaneously via a single-use, disposable and wearable on-body delivery system. We show 31 historical shares outstanding datapoints in our coverage of SCPH's shares outstanding history.
Understanding the changing numbers of SCPH shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like SCPH versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching SCPH by allowing them to research SCPH shares outstanding history
as well as any other stock in our coverage universe. |
Free SCPH Email Alerts:
Video: Shares Outstanding Importance
